Biophytis Analysis
Biophytis has over 8.27 Million in debt which may indicate that it relies heavily on debt financing. Biophytis' financial risk is the risk to Biophytis stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Biophytis' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Biophytis' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Biophytis Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Biophytis' stakeholders.
For most companies, including Biophytis, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Biophytis, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Biophytis' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Biophytis' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Biophytis is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Biophytis to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Biophytis is said to be less leveraged. If creditors hold a majority of Biophytis' assets, the Company is said to be highly leveraged.
Biophytis is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Biophytis delisted stock analysis is to determine its intrinsic value, which is an estimate of what Biophytis is worth, separate from its market price. There are two main types of Biophytis' stock analysis: fundamental analysis and technical analysis.
The Biophytis stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Biophytis is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Biophytis Stock trading window is adjusted to America/New York timezone.
Biophytis |
Biophytis Stock Analysis Notes
The company recorded a loss per share of 128.39. Biophytis had not issued any dividends in recent years. The entity had 1:40 split on the 23rd of April 2024. Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was incorporated in 2006 and is headquartered in Paris, France. Biophytis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Biophytis please contact Stanislas Veillet at 33 1 44 27 23 00 or go to https://www.biophytis.com.Biophytis Investment Alerts
| Biophytis is not yet fully synchronised with the market data | |
| Biophytis has some characteristics of a very speculative penny stock | |
| Biophytis has a very high chance of going through financial distress in the upcoming years | |
| Biophytishas 368,955 shares shorted by Biophytis investors is about 100% of outstending shares | |
| Net Loss for the year was (17.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biophytis currently holds about 23.93 M in cash with (13.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. |
Biophytis Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.61 M.Biophytis Outstanding Bonds
Biophytis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biophytis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biophytis bonds can be classified according to their maturity, which is the date when Biophytis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Biophytis Debt to Cash Allocation
Many companies such as Biophytis, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Biophytis currently holds 8.27 M in liabilities with Debt to Equity (D/E) ratio of 3.27, implying the company greatly relies on financing operations through barrowing. Biophytis has a current ratio of 1.34, which is within standard range for the sector. Note, when we think about Biophytis' use of debt, we should always consider it together with its cash and equity.Biophytis Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biophytis' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biophytis, which in turn will lower the firm's financial flexibility.Biophytis Corporate Bonds Issued
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biophytis to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |